Skip to main content
Clinical Trials/NCT03943199
NCT03943199CompletedNot Applicable

Randomized Clinical Trial: Comparison of Lysine Clonixinate, Ketorolac and Metamizole Sodium in Poisoning by Scorpion Stings

Mexican Red Cross2 sites in 1 country160 target enrollmentStarted: May 5, 2019Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
160
Locations
2
Primary Endpoint
Evaluate the efficacy of antivenom as a pain treatment by the visual analogue scale of pain in poisoning by scorpion stings.

Study Overview

Brief Summary

The cases of scorpion stings are matters of medical importance, where Mexico is considered as one of the main countries of such public health problem.

Detailed Description

The states with the highest incidence of cases in 2018 were Jalisco with 47370 bite reports, Guerrero with 40672 cases and Guanajuato with 40331, according to the national epidemiological surveillance system.

Due to the high affinity on ion channels, where a cystine inhibitor BmP01, it is directed to the nociceptive ion channel TRPV1 to produce pain.Pain has been reported to occur in approximately 97% of patients They are seen in the emergency room.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Sequential
Primary Purpose
Treatment
Masking
Triple (Participant, Care Provider, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Clinical diagnosis of pain by scorpion stings
  • Patients> 18 years old
  • Clinical diagnosis of scorpion sting poisoning grade I, II and III.
  • Chronic degenerative diseases (renal failure, hypertension, liver damage)

Exclusion Criteria

  • Patients who reject the continuation of medical treatment
  • Patients who are transferred to a unit of second level of care.
  • Patients with pharmacological treatment prior

Arms & Interventions

Metamizole sodium

Active Comparator

1 gram intravenous, will be diluted in 0.9% physiological solution of 100 ml, applied for 30 minutes

Intervention: Visual Analogue Scale for pain (Diagnostic Test)

Ketorolac

Active Comparator

60 milligrams intravenously, it will be added to 20 ml with 0.9% physiological solution, it will be applied for 5 minutes

Intervention: Visual Analogue Scale for pain (Diagnostic Test)

Lysine Clonixinate

Active Comparator

100 milligram intravenously, diluted in 5% glucose solution of 100 ml, applied for 30 minutes

Intervention: Visual Analogue Scale for pain (Diagnostic Test)

Placebo

Placebo Comparator

20 milliliters of 0.9% physiological solution, will be applied for 5 minutes.

Intervention: Visual Analogue Scale for pain (Diagnostic Test)

Outcomes

Primary Outcomes

Evaluate the efficacy of antivenom as a pain treatment by the visual analogue scale of pain in poisoning by scorpion stings.

Time Frame: 18 hours after drugs in study

Comparison of venom metabolism in patients valued at 18 hours with Visual Analog Scales (VAS) valued from 0 to 10

Secondary Outcomes

  • Evaluate the analgesic efficacy of clonixinate of lysine, ketorolac and sodium metamizol, by the visual analogue scale of pain in poisoning by scorpion stings.(0, 30, 60 and 90 minutes after administered the drug)

Investigators

Sponsor
Mexican Red Cross
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Josue Saul Almaraz Lira

Principal Investigator

Mexican Red Cross

Study Sites (2)

Loading locations...

Similar Trials

Comparison of Lysine Clonixinate,... | Clinical Trial